Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Octreotide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 known ✓ | P30874 | 15/20 | 0.57 |
| ▸ | SSTR5 known ✓ | P35346 | 11/20 | 0.57 |
| ▸ | SSTR4 known ✓ | P31391 | 8/20 | 0.57 |
| ▸ | SSTR3 known ✓ | P32745 | 5/20 | 0.54 |
| ▸ | SSTR1 known ✓ | P30872 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octreotide SCHEMBL6452623 | 0.88 | SSTR2 (0.45) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL725387 | 0.88 | SSTR2 (0.73) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL320745 | 0.87 | SSTR2 (0.76) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL19816086 | 0.81 | SSTR2 (0.74) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL2435867 | 0.79 | SSTR2 (0.71) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL6066965 | 0.78 | SSTR2 (0.73) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL15570084 | 0.78 | SSTR2 (0.65) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL16896858 | 0.78 | SSTR2 (0.72) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Octreotide SCHEMBL2330976 | 0.76 | SSTR2 (0.54) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL2830104 | 0.76 | SSTR2 (0.95) | SSTR2SSTR5SSTR4SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585461-A1 | 2,4- DIARYL - SUBSTITUTED [1,8]NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER | Merck Patent GmbH (DE) | 2013-05-01 | — | — | EP | disclosed |
| WO-2012000595-A1 | 2,4- DIARYL - SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER | MERCK PATENT GMBH (DE) | 2012-01-05 | — | — | WO | disclosed |